Exercise Training in Patients With Atrial Fibrillation (OPPORTUNITY Study)

Sponsor
Ottawa Heart Institute Research Corporation (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT02602457
Collaborator
(none)
94
1
2
179
0.5

Study Details

Study Description

Brief Summary

Atrial fibrillation is the most common heart rhythm disorder. The management of atrial fibrillation is of great importance. Despite the presence of exercise intolerance, weight gain, and an associated decline in overall health and well-being in patients living with atrial fibrillation, recommended standard care does not currently include the prescription of exercise to address these significant health issues. Exercise training is a recognized form of treatment of persons with heart disease. An exercise program such as high-intensity interval training when compared to moderate-intensity continuous exercise training may provide a stronger training stimulus for exercise and clinical outcomes; may be more efficient and motivating; and, may help to improve adherence to exercise training in persistent or permanent atrial fibrillation patients. This has been shown in patients with coronary artery disease and heart failure.

The primary objectives of this prospective study are to examine the impact of high-intensity interval training compared to moderate-intensity continuous exercise training in adults with persistent or permanent atrial fibrillation on exercise capacity and quality of life.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: moderate-intensity continuous exercise training
  • Behavioral: high-intensity interval training
N/A

Detailed Description

Atrial fibrillation is the most common heart rhythm disorder. Significant disease and death rates are associated with atrial fibrillation because of stroke risk, the complications of medications, poor quality of life and reduced exercise tolerance. Many patients report they have a lower quality of life because of this condition, so finding new ways of helping patients manage and cope with this health problem may help a great number of people. The management of atrial fibrillation is of great importance. Despite the presence of exercise intolerance, weight gain, and an associated decline in overall health and well-being in patients living with atrial fibrillation, recommended standard care does not currently include the prescription of exercise to address these significant health issues. Exercise training is a recognized form of treatment of persons with heart disease. An exercise program such as high-intensity interval training when compared to moderate-intensity continuous exercise training may provide a stronger training stimulus for exercise and clinical outcomes; may be more efficient and motivating; and, may help to improve adherence to exercise training in persistent or permanent atrial fibrillation patients. This has been shown in patients with coronary artery disease and heart failure.

The primary objectives of this prospective study are to examine the impact of high-intensity interval training compared to moderate-intensity continuous exercise training in adults with persistent or permanent atrial fibrillation on exercise capacity and quality of life.

Study Design

Study Type:
Interventional
Actual Enrollment :
94 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Investigator, Outcomes Assessor)
Primary Purpose:
Other
Official Title:
Exercise Training in Patients With Atrial Fibrillation (OPPORTUNITY Study)
Study Start Date :
Nov 1, 2015
Anticipated Primary Completion Date :
Jan 1, 2030
Anticipated Study Completion Date :
Oct 1, 2030

Arms and Interventions

Arm Intervention/Treatment
Experimental: Moderate-intensity continuous exercise

Moderate-intensity continuous exercise training

Behavioral: moderate-intensity continuous exercise training
Participants will complete supervised exercise sessions. Moderate-intensity continuous exercise training will follow cardiovascular rehabilitation guidelines. Participants will attend on-site moderate-intensity continuous exercise training two times weekly for 12 weeks.

Experimental: High-Intensity Interval Training

High-Intensity Interval Training

Behavioral: high-intensity interval training
Participants will complete supervised exercise sessions. Participants will attend on-site high-intensity interval training two times weekly for 12 weeks.

Outcome Measures

Primary Outcome Measures

  1. Change in quality of life as measured by the Short-Form 36 questionnaire [baseline to 12 weeks]

    Change in quality of life from baseline to 12 weeks as measured by the Short Form-36 questionnaire.

  2. Change in exercise capacity as measured by six-minute walk test distance [baseline to 12 weeks]

    Change in exercise capacity from baseline to 12 weeks as measured by six-minute walk test distance.

Secondary Outcome Measures

  1. Change in exercise adherence measured by accelerometer [baseline to 12 weeks]

    Change in exercise adherence from baseline to 12 weeks as measured by accelerometer.

  2. Change in activity status measured by the Duke Activity Status Index [baseline to 12 weeks]

    Change in activity status from baseline to 12 weeks as measured by the Duke Activity Status Index.

  3. Change in symptom burden measured by the Canadian Cardiovascular Society Severity of Atrial Fibrillation scale [baseline to 12 weeks]

    Change in symptom burden from baseline to 12 weeks as measured by the Canadian Cardiovascular Society Severity of Atrial Fibrillation scale.

  4. Change in symptom frequency and severity measured using the 7-day symptom diary [baseline to 12 weeks]

    Change in symptom frequency and severity from baseline to 12 weeks as measured using the the 7-day symptom diary.

  5. Change in disease specific quality of life will be measured using the University of Toronto Atrial Fibrillation Severity Scale (AFSS) [baseline to 12 weeks]

    Change in disease specific quality of life from baseline to 12 weeks will be measured using the University of Toronto Atrial Fibrillation Severity Scale (AFSS).

  6. Change in anxiety and depressive symptoms will be measured using the Hospital Anxiety and Depression Scale (HADS) [baseline to 12 weeks]

    Change in anxiety and depressive symptoms from baseline to 12 weeks will be measured using the Hospital Anxiety and Depression Scale (HADS).

  7. Change in sleep apnea risk will be measured by the STOP-BANG Sleep Apnea Questionnaire [baseline to 12 weeks]

    Change in risk of sleep apnea from baseline to 12 weeks will be measured by the STOP-BANG Sleep Apnea Questionnaire.

  8. Insomnia severity index will be measured using the Insomnia Severity Index [baseline to 12 weeks]

    Insomnia severity index at baseline and 12 weeks will be measured using the Insomnia Severity Index.

  9. Change in self reported sleep patterns will be measured using a 7-day sleep diary [baseline to 12 weeks]

    Change in self reported sleep patterns from baseline to 12 weeks will be measured using a 7-day sleep diary.

  10. Change in heart rate control will be measured using 24-hour Holter ECG recordings and ECG recordings at each cardiopulmonary exercise test (CPET) [baseline to 12 weeks]

    Change in heart rate control from baseline to 12 weeks will be measured using 24-hour Holter ECG recordings and ECG recordings at each cardiopulmonary exercise test (CPET)

  11. Change in muscular fitness will be measured using standard load tests [baseline to 12 weeks]

    Change in muscular fitness from baseline to 12 weeks will be measured using standard load tests.

  12. Change in exercise capacity will be measured using a cardiopulmonary exercise test (CPET) [baseline to 12 weeks]

    Change in exercise capacity from baseline to 12 weeks will be measured using a cardiopulmonary exercise test (CPET)

Eligibility Criteria

Criteria

Ages Eligible for Study:
40 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. persistent or permanent atrial fibrillation;

  2. rate controlled with a resting ventricular rate of equal to or less than 110 bpm;

  3. able to perform a symptom-limited exercise test;

  4. at least 40 years of age;

  5. patient agrees to sign informed consent.

Exclusion Criteria:
  1. currently participating in routine exercise training (more than two times per week);

  2. unstable angina;

  3. uncontrolled diabetes mellitus;

  4. diagnosed severe mitral or aortic stenosis;

  5. diagnosed hypertrophic obstructive cardiomyopathy with significant obstruction;

  6. unable to provide written, informed consent.

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Ottawa Heart Insititue Ottawa Ontario Canada K1Y 4W7

Sponsors and Collaborators

  • Ottawa Heart Institute Research Corporation

Investigators

  • Principal Investigator: Jennifer L Reed, PhD, Ottawa Heart Institute Research Corporation

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Ottawa Heart Institute Research Corporation
ClinicalTrials.gov Identifier:
NCT02602457
Other Study ID Numbers:
  • 20150427
First Posted:
Nov 11, 2015
Last Update Posted:
Apr 26, 2022
Last Verified:
Apr 1, 2022
Keywords provided by Ottawa Heart Institute Research Corporation
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 26, 2022